| Bioactivity | Triperiden is an inhibitor of influenza virus multiplication. Triperiden targets the haemagglutinin of fowl plague virus (FPV) for antiviral activity and acts by inhibiting the conformational change in the haemagglutinin at acid pH. Triperiden is also anticholinergic anti-parkinsonism drug[1]. | ||||||||||||
| Name | Triperiden | ||||||||||||
| CAS | 14617-17-5 | ||||||||||||
| Formula | C21H30ClNO | ||||||||||||
| Molar Mass | 347.92 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Ghendon Y, et al. Haemagglutinin of influenza A virus is a target for the antiviral effect of Norakin. J Gen Virol. 1986;67 ( Pt 6):1115-1122. |
Triperiden
CAS: 14617-17-5 F: C21H30ClNO W: 347.92
Triperiden is an inhibitor of influenza virus multiplication. Triperiden targets the haemagglutinin of fowl plague virus
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.